ArticleLiver cancer2026

An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final Analysis.

Markus Peck-Radosavljevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.